07Dec
Private Equity Dealmakers Guidebook to Healthcare M&A During the Covid-19 Pandemic
The COVID-19 pandemic has stressed the M&A market at every stage of the deal-making process – from complicating on-site visits and intensifying the diligence process to introducing valuation gaps (relative to pre-COVID-19 expectations), complicating purchase agreement negotiations and limiting the availability of debt financing. Despite these hurdles, healthcare dealmakers have continued to pursue attractive acquisition opportunities throughout 2020, with the healthcare M&A market substantially...
By:
Bass, Berry & Sims PLC
Related
On December 16, 2019, the IRS issued proposed regulations under Section 162(m) of the Internal Reven...
Read More >
The U.S. Securities and Exchange Commission (SEC) proposed a new exemptive order on Wednesday, Octob...
Read More >
Intel Corp. has reached a nearly $9 billion deal to sell its NAND flash memory unit to South Korea’...
Read More >
San Diego County Board of Supervisors declines to appeal ruling on climate plan - Patch – July 9 ...
Read More >
DEAMcon20 will inspire and empower you to reach higher levels in your career by offering a mix of fr...
Read More >
In 2020, the defense side ended a 15-year drought in litigating the fix. When the U.S. antitrust aut...
Read More >